The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations-Reference-Cited by-同舟云学术

The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutations

Published:2021-08-21 Issue:10 Volume:215 Page:460-464
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Hettipathirana Tamara¹²^ORCID,Macdonald Courtney²^ORCID,Xie Jing²,Moodie Kate²,Michael Chris²,Phillips Kelly‐Anne¹²^ORCID

Affiliation:

1. University of Melbourne Melbourne VIC

2. Peter MacCallum Cancer Centre Melbourne VIC

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/mja2.51226

Reference24 articles.

1. Australian Institute of Health and Welfare.Cancer data in Australia (AIHW cat. no. CAN 122). Updated 13 Nov 2020.https://www.aihw.gov.au/reports/cancer/cancer‐data‐in‐australia(viewed Dec 2020).

2. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

3. Cancer Institute NSW. BRCA1 or BRCA2: risk management (female) (ID 3814 v.1). eviQ Cancer Treatments Online; 2 July 2020.https://www.eviq.org.au/cancer‐genetics/adult/risk‐management/3814‐brca1‐or‐brca2‐risk‐management‐female(viewed Mar 2021).

4. BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women;Breast Cancer Research and Treatment;2024-05-26

2. Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review;Journal of Modern Oncology;2024-03-05

3. Breast cancer screening in germline mutation carriers. A literature review;Tumors of female reproductive system;2023-08-05

4. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline;Annals of Oncology;2023-01

5. The Value of Clinical Breast Examination, Imaging, and Fine Needle Aspiration and the Challenge of Diagnosing Breast Cancer in a Low Resource Setting: A Hospital-Based Analytical Study in Yaounde;Advances in Breast Cancer Research;2022